Prospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 98322
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.98322
Table 6 Comparison of clinical outcomes at baseline and 12 months for each group

Group 1 differences (n = 23)
P value
Cohen’s d effect size
Group 2 differences (n = 28)
P value
Cohen’s d effect size
Group 3 differences (n = 32)
P value
Cohen’s d effect size
Group 4 differences (n = 49)
P value
Cohen’s d effect size
Weight (kg)-3.70.47610.20.50.27320.00.50.56220.0-1.80.12020.1
BMI (kg/m2)-0.50.43610.1-0.10.86210.00.20.54410.0-0.20.46910.0
Waist circumference (cm)2.50.98420.01.70.95010.2-1.00.66520.2-1.30.66210.1
Glucose (mg/dL)-169.10.000a,12.6-121.40.000a,11.9-80.50.000 a,21.1-47.50.003a,20.5
LDL-C (mg/dL)-23.70.029a,10.7-28.50.09510.5-9.10.13510.3-20.10.14710.5
HDL-C (mg/dL)6.00.026a,20.46.40.000a,10.51.50.33110.1-2.00.65920.0
Triglyceride (mg/dL)-790.000a,10.7-15.00.43820.2-24.00.006a,20.3-29.00.006a,20.4
Total cholesterol (mg/dL)-24.0.002a,21.0-28.20.041a,10.4-17.30.011a,10.4-26.00.005a,20.6
C-peptide (ng/mL)0.00.78420.30.10.92710.1-0.30.14410.2-0.10.69220.0
HbA1c (%)-6.80.000a,14.5-3.80.000 a,22.6-3.60.000a,22.2-1.70.000a,21.3